Automation In Biopharma Industry Market Report 2026

Automation In Biopharma Industry Market Overview

• Automation In Biopharma Industry market size has reached to $2.19 billion in 2025 • Expected to grow to $3.16 billion in 2030 at a compound annual growth rate (CAGR) of 7.7% • Growth Driver: Rising Role Of Robotics In Pharmaceutical Manufacturing Fuels Expansion Of Automation In The Biopharma Industry • Market Trend: Adoption Of Robotic Automation Platforms In Biopharma Manufacturing To Enhance Efficiency • North America was the largest region in 2025.

What Is Covered Under Automation In Biopharma Industry Market?

Automation in the biopharma industry refers to integrating advanced technologies and robotics into various stages of the biopharmaceutical manufacturing process. It includes using automated systems and equipment to carry out tasks traditionally performed by humans, intending to increase efficiency, accuracy, and productivity in producing biopharmaceutical products. The main technologies in automation in biopharma industry are automation technology and digitization technology. Automation technology refers to the use of various technologies, such as robotics, artificial intelligence (AI), and software systems, to automate and streamline processes and tasks that were traditionally performed by humans. It includes components such as automation hardware, automation software, service project phases, and service operation phases, that are used in applications including clinical phases, drug discovery phases, and production phases.

What Is The Automation In Biopharma Industry Market Growth Forecast?

The automation in biopharma industry market size is expected to see strong growth in the next few years. It will grow to $3.16 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to increasing investments in smart biomanufacturing facilities, growing adoption of continuous manufacturing, expansion of personalized biologics production, rising demand for regulatory-compliant automation, increasing focus on manufacturing efficiency optimization. Major trends in the forecast period include increasing adoption of robotic manufacturing platforms, rising integration of digital twin technologies, growing use of automated quality control systems, expansion of end-to-end bioprocess automation, enhanced focus on data-driven manufacturing.

Global Automation In Biopharma Industry Market Segmentation

1) By Technology: Automation Technology, Digitization Technology 2) By Component: Automation Hardware, Automation Software, Services Project Phase, Services Operation Phase 3) By Application: Clinical Phase, Drug Discovery Phase, Production Phase Subsegments: 1) By Automation Technology: Process Automation, Laboratory Automation, Robotics And Artificial Intelligence, Control Systems, Programmable Logic Controllers (PLCs) 2) By Digitization Technology: Data Analytics And Visualization, Electronic Lab Notebooks (ELN), Cloud Computing, Internet Of Things (IoT) In Pharma, Digital Twin Technology

What Is The Driver Of The Automation In Biopharma Industry Market?

The increasing adoption of robots in pharmaceutical manufacturing is expected to propel the growth of automation in biopharma industry market. Robots in pharmaceutical manufacturing refer to advanced automated systems and machines that perform various tasks in producing and packaging pharmaceutical products. Robots are often used in multiple applications in pharmaceutical manufacturing, such as secondary packaging, intralogistics, laboratory automation, pick and place, automation of pharmacy processes, and personalized medicine, resulting in greater productivity, enhanced precision, reduced risk of contamination, and improved worker safety. For instance, in September 2024, according to the International Federation of Robotics, a Germany-based professional non-profit organization, industrial robot installations in the manufacturing industry in Europe increased by 9%, reaching a record high of 92,393 units. Of these, 80% were installed within the European Union, totaling 73,534 units a 2% rise from the previous year. Therefore, the increasing adoption of robots in pharmaceutical manufacturing will drive the growth of automation in biopharma industry industry.

Key Players In The Global Automation In Biopharma Industry Market

Major companies operating in the automation in biopharma industry market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, ABB Ltd, Siemens Healthineers AG, Emerson Electric Co., Becton Dickinson and Company (BD), Corning Incorporated, Rockwell Automation Inc., Agilent Technologies Inc., PerkinElmer Inc., Sartorius AG, bioMérieux SA, Mettler-Toledo International Inc., Beckman Coulter Inc., Waters Corporation, Pall Corporation, Bruker Corporation, Qiagen N.V., Eppendorf AG, Tecan Group Ltd., Promega Corporation, Brooks Automation Inc., Omron Automation, Hamilton Company, Integra Biosciences AG, Gilson Inc., Analytik Jena AG, BioTek Instruments Inc.

Global Automation In Biopharma Industry Market Trends and Insights

Major companies are operating the automation in biopharma industry market, focusing on developing technological advancements such as robotic cell-therapy manufacturing platforms for scalable, efficient, and error-reduced production of advanced therapies. A robotic cell-therapy manufacturing platform combines mobile robotics, aseptic fluid-handling systems, automated tube welding, and digital process control into a fully closed and modular system, replacing traditional manual bioprocessing that relies heavily on labor and open systems. For instance, in May 2023, Cellular Origins, a UK-based life sciences automation company, launched Constellation, a configurable robotic platform for advanced therapy manufacture. The platform integrates autonomous mobile robots, sterile fluid-transfer technology, and modular processing consoles, allowing seamless integration with existing bioprocessing workflows. It boosts space efficiency by 30 times, reduces labor requirements by 16-fold, and cuts production costs by 51%, while offering full digital interconnection for quality control and remote monitoring.

What Are Latest Mergers And Acquisitions In The Automation In Biopharma Industry Market?

In January 2024, Bruker Corporation, a US-based provider of high-performance scientific instruments and analytical systems, acquired Chemspeed Technologies AG for an undisclosed amount. Through this acquisition, Bruker aims to accelerate the digital transformation of R&D and quality control laboratories in the biopharma and life sciences industries by integrating Chemspeed’s modular automated laboratory and robotics workflow solutions. Chemspeed Technologies AG is a Switzerland-based company that provides modular automation and robotics workstations for laboratory R&D and quality control workflows.

Regional Outlook

North America was the largest region in the automation in biopharma industry market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Automation In Biopharma Industry Market?

The automation in biopharma industry market consists of revenues earned by entities by providing high-throughput screening, sample management, and cell culture automation used during the process. The market value includes the value of related goods sold by the service provider or included within the service offering. The automation in biopharma industry market also includes sales of automated dissolution testing systems, robotic sample storage and retrieval systems, and chromatography systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Automation In Biopharma Industry Market Report 2026?

The automation in biopharma industry market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the automation in biopharma industry industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.